0 Commentarii
0 Distribuiri
1452 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
- Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
- Antisense Oligonucleotides Market Key Players Profile Outlook and Forecast Till 2032The Reports and Insights, a leading market research company, has recently releases report titled “Antisense Oligonucleotides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Antisense Oligonucleotides Market share, size, trends, and growth forecasts. The report...0 Commentarii 0 Distribuiri 469 Views 0 previzualizare
- Antisense Oligonucleotides Market Size is Witnessing to Grow at a CAGR of 9.5% from 2023 to 2032The global Antisense Oligonucleotides market size exceeded US$ 1.7 billion in 2021 and is anticipated to expand at a CAGR of 9.5% from 2023 to 2032. The exhaustive Global Antisense Oligonucleotides market report focuses on the important aspects of the market imbibing recent global trends are. The market research report refers to production capacity, consumption, import, and export for all major...0 Commentarii 0 Distribuiri 1917 Views 0 previzualizare
- Emerging Antisense Oligonucleotides Market driven by Increasing R&D Investment in Therapeutics DevelopmentAntisense oligonucleotides work by binding to messenger RNA (mRNA), which stops the production of proteins present in the mRNA. They have gained popularity in treating rare genetic diseases such as spinal muscular atrophy, cardiovascular diseases, and cancer. The market growth is driven by rising investment in research and development for therapeutics discovery and development of novel...0 Commentarii 0 Distribuiri 1193 Views 0 previzualizare
- The Antisense Oligonucleotides Market is Estimated to Witness High Growth Owing to Opportunity in Rare Diseases TreatmentAntisense oligonucleotides are synthesized short DNA or RNA strands that bind to messenger RNA (mRNA) and prevent protein synthesis by either degrading the target mRNA or blocking its translation. These oligonucleotides are used to treat rare diseases caused by single-gene mutations such as Duchenne muscular dystrophy and spinal muscular atrophy. The global antisense oligonucleotides market is...0 Commentarii 0 Distribuiri 1205 Views 0 previzualizare